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Original Article
Surgical Correction of Supravalvar Aortic
Stenosis: 52 Years’ Experience
Rosa Roemers, MD1,2,3, Jolanda Kluin, MD, PhD1,2,
Frederiek de Heer, MSc2, Sara Arrigoni, MD3,
Regina Bo¨kenkamp, MD, PhD1, Joost van Melle, MD, PhD4,
Tjark Ebels, MD, PhD3, and Mark Hazekamp, MD, PhD1,2
Abstract
Objectives: Supravalvar aortic stenosis (SVAS) is a rare congenital anomaly. The “single-patch technique,” “‘two sinus aug-
mentation with an inverted Y-patch” (both nonsymmetrical corrections), “three-patch technique,” and the “slide aortoplasty”
(both symmetrical corrections) are the techniques implemented by the majority of surgeons for the correction of SVAS. In the
few studies that compared these techniques, no technique was shown to be superior over another. The aim of the present study is
to review the 52-year experience with the surgical correction of SVAS in two of four congenital cardiothoracic surgical centers in
the Netherlands.Methods:We retrospectively reviewed all patient files of those who underwent an operation to correct their
SVAS, between 1962 and 2014 in our centers. Patients were divided according to their operating technique. These groups were
compared using the end points freedom from reoperation and mortality. Results: A total of 49 patients were included,
23 (46.9%) patients in the nonsymmetrical group and 26 (53.1%) patients in the symmetrical group. Survival after 20 years in the
nonsymmetrical group was 80% (standard error [SE]: 0.091) and in the symmetrical group was 85% (SE: 0.085; P¼ .163). Freedom
from reoperation after 20 years in the nonsymmetrical group was 88% (SE: 0.079) and in the symmetrical group was 71% (SE:
0.107; P ¼ 0.313). Conclusion: In this patient group, there is no significant difference in survival and freedom from reoperation
between the different surgical techniques for SVAS repair. Compared to the survival in the general population, the survival of
SVAS patients is remarkably low. Apparently, SVAS is not a benign disease and probably patients should be followed more closely
for the rest of their lives.
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Introduction
Supravalvar aortic stenosis (SVAS) is a rare congenital cardiac
anomaly and a common feature of Williams-Beuren syndrome,
but it also occurs as the result of an isolated autosomal domi-
nant trait.1,2 A deletion of the elastin gene causes narrowing of
large elastic arteries like the aorta or pulmonary arteries. The
narrowing of the aorta is seen characteristically in the supra-
valvar aorta at the sinutubular junction, this is the so-called
“discrete” type of SVAS. When the stenosis extends into the
ascending aorta, aortic arch, or the origin of the arch vessels,
this is called the “diffuse” type of SVAS.2,3 The incidence of
discrete SVAS widely varies (14%-72%) in studies reporting
their results of the surgical correction of SVAS.4–9 Several
SVAS-associated lesions have been described: stenosis of the
coronary arteries, bicuspid aortic valve, subvalvar aortic steno-
sis, and pulmonary stenosis.3 Supravalvar aortic stenosis is
known to be a progressive lesion.4,5 Various variations in
operative techniques have been described, which differ by the
number of Valsalva sinuses that are augmented by (patch)
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repair. The “single-patch technique,” “two sinus augmentation
with an inverted Y-patch” (both nonsymmetrical correction),
and the “three-patch technique” (symmetrical correction) are
the techniques implemented by the majority of surgeons for the
surgical correction of SVAS (Figure 1). It is unknown whether
any of these techniques leads to superior results. The aim of the
present study is to review the 52 years’ experience with the
surgical correction of SVAS in two of four congenital cardi-
othoracic surgical centers in the Netherlands
Patients and Methods
Study Design and Setting
This is a retrospective observational study conducted in two
centers in the Netherlands: the Center for Congenital Heart
Diseases Amsterdam Leiden CAHAL that includes Leiden
University Medical Center, Academic Medical Center Amster-
dam, and Free University Medical Center Amsterdam ; and the
University Medical Center Groningen. To collect data of all
patients who underwent surgery for SVAS, the cardiology and
cardiac surgery databases of the different institutions were
reviewed. All patients who underwent surgery for SVAS from
1962 until 2014 in one of these centers were included. Patients
were excluded when they had acquired postsurgical SVAS or
when they underwent SVAS correction and aortic valve
replacement in the same initial operation. This study was
notified to the medical ethics committee, but because of the
observational character of the study it is not part of the Wet
Medisch-wetenschappelijk Onderzoek¼ LawMedical Research
and did not need approval by the medical ethics committee.
Data Collection
We collected the following demographic and preoperative
data: gender, date of birth, date of initial surgical SVAS cor-
rection, syndrome determined by genetic testing, previous car-
diovascular operation, form of SVAS (discrete or diffuse), and
concomitant preoperative cardiovascular anomalies. Operative
data included the operation technique used at the initial surgical
SVAS correction (divided in single-patch technique, two sinus
augmentation, and three-patch technique; sliding plasty was
not performed in our centers), additional surgical procedures at
initial operation, patch material used, complications during the
operation, and in-hospital complications during postoperative
stay. Follow-up data included restenosis on echo, reoperations
in the cardiovascular area, and mortality and were collected at
the last follow-up appointment with the cardiologist. Any gra-
dient over the supravalvular area that was higher than the gra-
dient directly postoperative was considered a restenosis. The
echocardiographic data of all available echocardiographs were
analyzed by one cardiologist (R.B.), Z scores were used accord-
ing to Pettersen et al.6 Aortic valve disease was defined as valv-
ular stenosis (from mild to severe), regurgitation (from mild to
severe), bicuspid aortic valves, or adhesion of one or more leaf-
lets to the supravalvular ridge. For every patient, the general
practitioner was consulted in order to check the patients’ well-
being. If a patient had deceased, as much as possible information
were collected regarding the cause of death. End points were
survival rate and freedom from reoperation.
Statistical Analysis
In order to identify significant differences in baseline charac-
teristics between the two surgical groups (symmetrical vs non-
symmetrical), an independent-sample t test was performed for
parametric continuous variables. For nonparametric continuous
variables, the Mann-Whitney U test was used. For categorical
variables, a w2 test was used. When expected cell count was less
than 5 in >20% of the cases, the Fisher exact test was used. A
P value of <.05 was considered significant. The survival and
reoperation-free survival of the symmetrical and nonsymme-
trical groups were described using the Kaplan-Meier curves.
The binary logistic regression analysis was used to compare
survival rate and freedom of reoperation rate between the
2 groups at 20 years. Due to the observational character of the
study, correcting for selection bias was indicated. This was
done by performing a separate logistic regression analysis to
assess the propensity score for each patient. Based on selected
Figure 1. Three surgical techniques. A, Single-patch technique. B, Two-sinus augmentation with an inverted Y-patch. C, Three-patch technique.
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patient characteristics that are considered to be confounding
factors, the propensity score predicts the chance that a patient
will belong to the symmetrical or nonsymmetrical group. We
considered sex, age at first SVAS correction operation, year of
operation, presence of Williams syndrome, presence of pul-
monary artery stenosis, and presence of aortic valve disease
as potential factors to cause selection bias (confounders). We
plotted the propensity scores to check whether the overlap was
sufficient. The calculated propensity scores were then added to
the model to correct the odds for mortality and freedom of
reoperation. We used this logistic regression analysis to com-
pare symmetrical and nonsymmetrical operating techniques in
survival and reoperation-free survival. The statistical software
system IBM SPSS 22 was used for data analysis.
Results
Patient and Operative Characteristics
From 1962 to 2014, a total of 49 patients underwent surgical
relief of SVAS. Williams syndrome was present in 24 (49%)
patients and Noonan syndrome in 2 (4.1%) patients . An iso-
lated elastin (ELN) mutation was demonstrated in three (6.1%)
patients, and in two cases no genetic test was performed. In
42 (85.7%) patients, SVAS was discrete and in 7 (14.3%)
patients it was diffuse (Table 1). The mean age at the time of
the first operation was 8.16 (standard deviation [SD] ¼ 9.25)
years (range: 0-45 years). This wide range is the result of a
change in surgical practice over time. After 1974, all patients
were operatedonas children.Concomitant cardiovascular anoma-
lies are specified in Table 2. Twenty-one (42.9%) patients needed
additional procedures during their first SVAS operation. Four
(8.2%) needed aortic arch surgery.Others underwent enlargement
of pulmonary artery stenosis (n ¼ 5), clipping of patent ductus
arteriosus (n¼ 3), mitral valve repair (n¼ 3), aortic valve repair
(n¼ 3), valvulotomy of the aortic valve (n¼ 2), and valvulotomy
of the pulmonary valve (n¼ 1). In 15 (30.6%) patients, untreated
autologous pericardiumwas used as patchmaterial; in 20 (40.8%)
patients, glutaraldehyde-treated autologous pericardium was
used; in 10 (20.4%) patients synthetic material was used; in
2 (4.1%) patients dura mater was used; in 1 (2.0%) patient xeno-
pericardiumwas used; and in 1 (2.0%) patient an aortic homograft
was used to create a patch. The use of duramater took place solely
in the earlier years of our experience.
We divided the patients in two groups: 23 (46.9%) patients
were operated on using the nonsymmetrical techniques (22.4%
using the single-patch technique and 24.5% using the two sinus
augmentation) and 26 (53.1%) patients were operated using the
symmetrical (three-patch) technique.
Mortality
Follow-up was 100% complete. The mean follow-up time was
19.2 years (SD: 12.8, median 19). The longest follow-up time
was 52 years. A total of eight (16.3%) patients died, of which
Table 1. Baseline Characteristics: Preoperative.
Variablesa Overall, N ¼ 49 Nonsymmetrical, n ¼ 23 Symmetrical, n ¼ 26 P Value
Sex .445
Female 27 55.1% 14 60.9% 13 50.0%
Male 22 44.9% 9 39.1% 13 50.0%
Syndrome <.01
No syndrome identified 18 36.7% 15 65.2% 3 11.5%
Williams-Beuren 24 49.0% 5 21.7% 19 73.1%
Noonan 2 4.1% 1 4.3% 1 3.8%
ELN mutation de novo 3 6.1% 0 0.0% 3 11.5%
Unknown 2 4.1% 2 8.7% 0 0.0%
Form of SVAS .011
Discrete 42 85.7% 23 100% 19 73.1%
Diffuse 7 14.3% 0 0.0% 7 26.9%
Age at operation .097
Mean 8.2 (+9.3) 8.9 (+7.1) 7.5 (+10.9)
Median 6 (2.0-11) 6 (4.0-13) 4 (2.0-9.0)
Year of operation <.01
Before 1978 8 16.3% 8 34.8% 0 0.0%
After 1978 41 83.7% 15 65.2% 26 100%
Presence of pulmonary artery stenosis .017
Yes 17 34.7% 4 17.4% 13 50.0%
No 32 65.3% 19 82.6% 13 50.0%
Presence of aortic valve disease .013
Yes 8 16.3% 6 26.1% 2 7.7%
No 41 83.7% 17 73.9% 24 92.3%
Abbreviation: ELN, elastin.
aCategorical data are presented as number of patients and continuous data as mean (+ standard deviation) and interquartile range (Q1-Q3).
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two were early deaths and six late deaths (Table 3). Of the six
late deaths, four were out-of-hospital cardiac arrests, the age of
dead patients varied between 33 and 57 years, and only one
patient was diagnosed with Williams syndrome. The actuarial
survival of all patients at ten years was 94% (standard error
[SE]: 0.035), at 20 years 81% (SE: 0.067), at 30 years 81% (SE:
0.067), and at 40 years 68% (SE: 0.135). In the nonsymmetrical
group, actuarial survival at 10 years was 96% (SE: 0.043), at 20
years was 80% (SE: 0.091), at 30 years was 80% (SE: 0.091),
and at 40 years was 67% (SE: 0.143; Figure 2). In the symme-
trical group, actuarial survival at ten years was 92% (SE: 0.056)
and at 20 years was 85% (SE: 0.085). The odds of death were
not significantly higher for patients in the nonsymmetrical
group with an adjusted odds ratio of 0.116 (95% CI: 0.006-
2.396; P ¼ .163).
Reoperation
A total of eight (16.3%) patients were reoperated, involving
three early reoperations and five late reoperations (Table 4).
All techniques combined, the total percentage of patients free
from reoperation was 92% (SE: 0.040) after 10 years and 79%
(SE: 0.067) after 20 years. In the nonsymmetrical group, free-
dom from reoperation after 10 years was 100% and after 20
years 88% (SE: 0.079). There were no reoperations performed
on the patients at risk in the nonsymmetrical group more than
20 years after their initial operation (Figure 3). In the symme-
trical group, freedom from reoperation after 10 years was 84%
Table 2. Concomitant Cardiovascular Anomalies.
Concomitant Cardiovascular Anomalies Frequency
Peripheral pulmonary artery stenosis 14a (28.6%)
Localized aortic coarctation 5 (10.2%)
Bicuspid aortic valve 3 (6.1%)
Aortic valvular stenosis 3 (6.1%)
Mitral valve insufficiency 3 (6.1%)
Supravalvular pulmonary artery stenosis 3 (6.1%)
Patent ductus arteriosus 3 (6.1%)
Aortic valve regurgitation 2 (4.1%)
Ascending aortic aneurysm 2 (4.1%)
Coronary artery stenosis 2 (4.1%)
Hypoplastic ascending aorta 2 (4.1%)
Pulmonary valve stenosis 1 (2.0%)
Left carotid artery 1 (2.0%)
Right ventricle hypertrophy 1 (2.0%)
Patent foramen ovale 1 (2.0%)
Arteria lusoria 1 (2.0%)
aNumbers refer to patients with any of the respective anomalies, and presence
of more than one anomaly in one patient is possible.









Preoperative Techniqueb Reoperation Cause of Death
1. M 10 10 (in-hospital
mortality)





1 – Severe left ventricular hypertrophy
led to subendocardial infarction








3 Yes Severe left ventricular hypertrophy,
arrhythmias, pulmonary
dysfunction ! ECMO
procedure! complicated by a
blood clot obstruction !
cardiac arrest
3. M 19 40 – Discrete – 1 – OHCA
4. M 45 49 – Discrete -Mitral valve
regurgitation
3 Yes OHCA
5. M 39 57 – Discrete – 3 Yes OHCA
6. M 15 33 Williams Discrete – 2 – OHCA
7. F 7 20 Williams Discrete -Peripheral
pulmonary
artery stenosis
2 – Right ventricular failure








Abbreviations: F, female; M, male; OHCA, out-of-hospital cardiac arrest.
aAge in years or months if stated.
bOperating technique: 1, single-patch technique; 2, two-sinus augmentation; 3, three-patch technique.
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(SE: 0.072) and after 20 years was 71% (SE: 0 .107). The odds
of freedom of reoperation were not significantly higher for
patients in the nonsymmetrical group compared to the symme-
trical group: adjusted odds ratio: 0.156, 95% CI: 0.004-5.773;
P ¼ .313. The Kaplan-Meier curve for freedom from reopera-
tion (Figure 3) shows a marked lower curve for the symmetrical
group, mainly due to more frequent early reoperations in the
symmetrical group.
Echocardiography
The echocardiographic follow-up was incomplete due to the
retrospective character of the study. Some patients did not visit
their cardiologist regularly and some were followed up without
echocardiographic imaging. Echocardiographic images that
were suitable for analysis were available in 13 patients
(26.5%), 9 of whom were operated with the nonsymmetrical
technique and 4 with the symmetrical technique. None of the
patients showed a significant restenosis of the supravalvular
area (Figure 4).
Discussion
This study did not show a significant difference in mortality
and reoperation rates between an asymmetrical and symmetri-
cal correction of SVAS. Interestingly, compared to the survival
in the general population, the long-term survival of SVAS
patients is remarkably low.
The most common reason for reoperation identified in the
present study was aortic valve replacement, which was identi-
fied in previous studies as well.7–19 Enlarging the aortic root
Figure 2. Kaplan-Meier survival curve. The numbers of patients
belonging to the nonsymmetrical group are shown in blue, the num-
bers of patients in the symmetrical group are shown in green.










Preoperative Techniqueb Reoperation Specifications









2. Mc 45 49 – Discrete Mitral valve
regurgitation
3 Mitral valve replacement





3 Aortic arch repair
4. Mc 39 42 – Discrete 3 Aortic valve replacement




3 Aortic valve replacement




3 Replacement of ascending-, descending- and
aortic arch by vascular prosthesis
7. F 23 39 – Discrete Aortic valvular
stenosis
2 Aortic valve replacement
8. Fc 1 21 – Discrete Patent ductus
arteriosus mitral
valve regurgitation
1 First reoperation: aortic valve replacement
mitral valve replacement enlargement
ascending aorta second reoperation:
mitral valve replacement (larger
prosthesis) tricuspid valve repair
Abbreviation: SVAS, supravalvar aortic stenosis; ECMO, extracorporeal membrane oxygenation.
aAge in years or months if stated.
bOperating technique: 1, single-patch technique; 2, two-sinus augmentation; 3, three-patch technique.
cDeceased.
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could theoretically lead to aortic regurgitation, because the
aortic cusps might not be sufficient for the “new”aortic root
geometry. A nonsymmetric repair would more likely cause an
unbalanced aortic valve, causing regurgitation as well. Four
patients needed aortic valve replacement. Two patients were
operated with the symmetrical technique, one had aortic valve
regurgitation and the other patient had aortic valve stenosis.
Two patients were operated on with the nonsymmetrical tech-
nique, one had aortic valve regurgitation and the other patient
had aortic valve stenosis. Other studies also did not find dif-
ferences between the groups, mainly due to the small reopera-
tion rates or short follow-up time.3,4,9–19 The results of the
single-center study of Metton et al actually showed that at the
last follow-up the lowest incidence of moderate aortic regur-
gitation was found in the three-patch technique group com-
pared to the one- and two-patch technique groups.17
Previous studies showed that the presence of diffuse SVAS
is a possible predictor of early and late mortality.20 In the
present study, of the patients who died (n ¼ 8), seven had
discrete SVAS and one had diffuse SVAS. Because of the small
incidence of diffuse SVAS (n¼ 7) in this study, no conclusions
can be drawn concerning the form of SVAS as a predictor of
mortality. Previous studies show low early mortality rates
(1%-5%) and when follow-up time increases, both mortality
rates and reoperation rates rise. These studies show ten-year
survival rates of 84% and 95%, and 20-year survival rates of
70% and 90%.9,10,12,16,21 Our study reports the longest follow-
up. Our results show a rise of both mortality and reoperation
rate after the first decade (10-year survival: 94%, 20-year
survival: 81%, and 40-year survival of only 68%; 10 years
of freedom from reoperation: 92% and 20 and 40 years of
freedom from reoperation: 79%). The survival in 1962,
1988, and 2014 in these age groups was >99% among the
general population in the Netherlands.22 Thus, compared to
the survival in the general population, the survival of SVAS
patients in our study is remarkable low.
Four of the six late deaths were out-of-hospital cardiac
arrests. These four patients died at an age between 33 and 57
years. No autopsies were conducted. All were operated on for
discrete SVAS and one had Williams syndrome. They all were
operated on at a relatively old age (>14), therefore, we could
argue that the coronary arteries were exposed to a high pressure
in the prestenotic area for a relatively long period of time,
which might have caused endothelial damage leading to
ischemic heart disease as a cause for their sudden cardiac
arrest. In two of these late deaths, echocardiography was con-
ducted, respectively, one and two years prior to death, showing
no abnormalities. This remarkably high mortality rates consid-
ering the character of the surgery, of which a high percentage
out-of-hospital cardiac arrests makes us plead for a closer (pre-
ferably lifelong) follow-up of patients after surgical correction
of SVAS including exercise capacity and Holter monitoring.
Strength and Limitations
Even though this study has the longest follow-up time (52
years) ever reported in patients operated for SVAS with a mean
length of follow-up of 19.2 years (SE: 1.8), and although this
study includes patients from two of four congenital heart sur-
gery centers in the Netherlands, the study population consisted
of only 49 patients. Also the majority of the patients included
have a follow-up of less than equal to ten years, the number of
patients declines fast after this point, and therefore it is difficult
to draw conclusions after this point. A strong feature of this
study is that the different operating techniques are well divided
over the population: nonsymmetrical techniques (46.9%) and
symmetrical technique (53.1%). Most other studies show
higher percentages for one particular technique. Nevertheless,
in order to compare those two groups by means of a binary
logistic regression analyses, a sample size of 49 patients is too
small. As Long stated, sample sizes of <100 should be avoided
in these analyses and a sample size of 500 or more should be
adequate for almost any situation.23 The rareness of this disease
makes it very difficult to obtain a high number of patients in
Figure 3. Kaplan-Meier reoperation-free survival. The numbers of
patients belonging to the nonsymmetrical group are shown in blue,
the numbers of patients in the symmetrical group are shown in green.
Figure 4. Echocardiographic gradients.
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one country.24 As all other studies that are conducted in this
field so far, all have study populations of less than 100, the
question rises what these conclusions really tell us.3,4,9–19
A meta-analysis would be an option. As shown in Table 1, the
two groups are significantly different on various characteris-
tics. We corrected for these differences and potential confound-
ing factors by means of the propensity scores. Nevertheless,
this will not provide total equalization of the groups. Unmea-
sured confounders will still be there, for example, the form of
SVAS could not be matched using propensity scoring because
the number of patients was too small. Nevertheless, all seven
patients with the diffuse form of SVAS were in the symmetrical
group. This might be considered an unmeasured confounding
factor. Also all patients operated on before 1978 belonged to
the nonsymmetrical group, and this group had a higher percent-
age of preoperative pulmonary artery stenosis. This cohort is
too small to state that one confounder might influence the
results more than another or might influence the results at all.
In our cohort, there were only three patients with SVAS and
a bicuspid aortic valve, all three were operated on with a non-
symmetrical technique. Based on our present experience, we do
not prefer a nonsymmetrical over a symmetrical reconstruction
in patients with a bicsupid aortic valve. We would enlarge the
sinuses with one or two patches depending on what looks best.
We took survival and reoperation as end points. In both
groups, there were eight events. The small cohort and the
relatively small number of events with the end point reopera-
tion are limitations of this study. The lack of additional infor-
mation regarding those deaths is another limitation, as is the
less than optimal echocardiographic follow-up percentage
(74%) for this cohort.
Conclusions
In this patient group, there was no significant difference in
survival and freedom from reoperation between the different
surgical techniques for SVAS repair. Compared to the survival
in the general population, the survival of SVAS patients is
remarkably low. Apparently, SVAS is not a benign disease and
probably patients should be followed more closely for the rest
of their lives.
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